Evaluation of International Normalized Ratios by a Controlled Field Survey with 4 Different Thromboplastin Reagents

Summary

A nationwide survey has been performed in Japan involving 75 laboratories to assess the relative reliability of different methods of reporting prothrombin time results in anticoagulant control. The interchangeability of results using prothrombin time, prothrombin activity percentage, prothrombin ratio and international normalized ratios (INR) were compared with four different thromboplastin reagents and a range of coagulometers. A secondary batch of reference thromboplastin of human brain origin (BCT/454) was used to calibrate the local thromboplastins and for comparison of methods of reporting. The study revealed the closest agreement of the results between BCT and the other reagents, and the regression lines of these reagents were almost identical, when the results were reported as INR. Box-Whisker plot analysis showed that the distribution of the results was large with the more deficient plasmas with all methods of reporting. It was found by this analysis that the interchangeability of the results was greatest when the results were expressed by INR, because the mean values obtained of each plasma using different thromboplastin reagents gave the lowest CV and the frequency of the far-out data was least, compared with the other methods of expression. On the other hand, the type of coagulometer had almost as much effect as the thromboplastin reagent on the prothrombin time, even if INR was used. Interchangeability of INR would be further improved by providing ISI values for each reagent/ instrument combination.

• References

• 1 WHO Expert Committee on Biological Standardization. 33 Report WHO Tech Rep Ser 1983 687. 81-105
• 2 Loeliger EA, Poller L, Samama M, Thomson JM, van den Besselaar AM, Vermylen J, Verstraete M. Questions and answers on prothrombin time standardization in oral anticoagulant control. Thromb Haemostas 1985; 54: 515-517
• 3 Beck EA. How can we improve long-term anticoagulation. Schweiz Med Wochenschr 1985; 115: 1495-500
• 4 Lechner K, Kroninger C, Kyrle P, Geissler K, Niessner H, Pabinger I, Panzer S, Gossinger H, Betterheim P, Hinterberger W. Oral anticoagulant therapy - Renaissance of an old therapy. Wien Klin Wochenschr 1987; 99: 203-210
• 5 Poller L. INR-calibration of the therapeutic range. Adv Exp Med Biol 1987; 214: 95-112
• 6 Hull R, Hirsh J, Jay R, Carter C, England C, Gent RN M, Trupie AG G, McLoughlin D, Didd P, Thomas M, Raskab G, Ockelford P. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med 1982; 307: 1676-1681
• 7 Hermans J, van den Besselaar AM P H, Loeliger EA, van den Velde EA. A collaborative calibration study of reference materials for thromboplastins. Thromb Haemostas (Stuttgart) 1983; 50: 712-717
• 8 Poller L, Taberner DA. Dosage and control of oral anticoagulants: An international Survey. Br J Haematol 1982; 51: 479-485
• 9 Poller L. Laboratory control of anticoagulant therapy. Sem Thromb Hemostas 1986; 12 (01) 13-19
• 10 Tukey JW. Exploratory Data Analysis. Addison-Wesley, Reading, MA 1977; 339
• 11 Thomson JM, Tomenson JA, Poller L. The calibration of the second primary international reference preparation for thromboplastin (thromboplastin, human, plain, coded BCT/253). Thromb Haemostas 1984; 52: 336-343
• 12 Hirsh J. Effectiveness of anticoagulation. Sem Thromb Hemostas 1986; 12: 1-35
• 13 Loeliger EA, van den Besselaar AM H P, Lewis SM. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control. Thromb Haemostas 1985; 53: 148-154
• 14 Lammle B, Furlan M, Sulzer I. Comparison of a sensitive rabbit brain thromboplastin and a human placenta thromboplastin for thromboplastin time determination. Schweiz Med Wochenschr 1989; 119: 178-83
• 15 Taberner DA, Poller L, Thomson JM, Darvy KV. Effect of international sensitivity index (ISI) of thromboplastin on precision of international normalized ratios (INR). J Clin Pathol 1989; 42: 92-96
• 16 Palareti G, Coccheri S, Poggi M, Bonetti M, Cervi V, Mazzuca A, Savoia M, Veri L, Fiori F, Gaspari G. et al. Oral anticoagulant therapy control: Evidence that INR expression improves the inter-laboratory comparability of results - the Bologna oral anticoagulant control exercise. Thromb Haemostas 1987; 58: 905-910
• 17 Evatt BL, Brogan D, Triplett DA, Waters G. Effect of thromboplastin and instrumentation on the prothrombin time test. Clin Lab Haematol 1981; 3: 331-342
• 18 Triplett DA, Evatt BL, van den Besselaar AM H P. Proficiency testing and standardization of prothrombin time: Potential use of thromboplastin calibration in the United States. In: Thromboplastin Calibration and Oral Anticoagulant Control van den Besselaar AM H P, Gralnick HR, Lewis SM. (eds). Martinus Nijhoff Publishers; Boston, MA: 1984: 209-218
• 19 van den Besselaar AM. Standardization of the prothrombin time in oral anticoagulant control. Haemostasis 1985; 15: 271-277
• 20 Poller L, Hirsh J. Special report: a simple system for the derivation of international normalized ratios for the report of prothrombin time results with North American Thromboplastin reagents. Am J Clin Pathol 1989; 92: 124-126
• 21 Poller L. A simple nomogram for the derivation of international normalized ratios for the standardization of prothrombin times. Thromb Haemostas 1988; 60: 18-20